AUP.TO Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 Dec 1970 @ 19:00):

Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops and commercializes therapies to treat various diseases in the United States and China...

Stats
Today's Volume	4.61M
Average Volume	314 255
Market Cap	0.00
EPS	$-0.370 ( 2021-08-05 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-11.45
ATR14	$0 (0.00%)

Aurinia Pharmaceuticals Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Aurinia Pharmaceuticals Financials

Annual	2020
Revenue:	$50.12M
Gross Profit:	$-209 000 (-0.42 %)
EPS:	$-1.104

FY	2020
Revenue:	$50.12M
Gross Profit:	$-209 000 (-0.42 %)
EPS:	$-1.104

FY	2019
Revenue:	$318 000
Gross Profit:	$-52.55M (-16 524.53 %)
EPS:	$-1.330

FY	2018
Revenue:	$463 000
Gross Profit:	$-40.92M (-8 837.80 %)
EPS:	$-0.760

Financial Reports:

No articles found.

Aurinia Pharmaceuticals Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Aurinia Pharmaceuticals

Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops and commercializes therapies to treat various diseases in the United States and China. It is involved in developing voclosporin, an investigational drug for the treatment of lupus nephritis, dry eye syndrome, and focal segmental glomerulosclerosis. The company is headquartered in Victoria, Canada.